Champions Oncology (CSBR) vs MindWalk (HYFT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Champions Oncology (CSBR) has outperformed MindWalk (HYFT) over the past year, losing 23.0% versus a loss of 23.5%. Over five years, CSBR leads with a -50.6% price change compared with -78.3% for HYFT. MindWalk is the larger company by market cap ($70.7 million vs $69.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | HYFT |
|---|---|---|
| Share price | $4.98 | $1.50 |
| Market cap | $69.31M | $70.67M |
| 1-day change | 0.00% | +4.90% |
| YTD return | -27.93% | -21.43% |
| 1-year return | -23.03% | -23.53% |
| 5-year return | -50.60% | -78.27% |
| Forward P/E | 49.80 | — |
| EPS (TTM) | $-0.07 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $2.99 |
| 52-week low | $4.59 | $0.99 |
| Distance from 52-week high | -40.07% | -49.83% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +188.67% |
| Average volume | 11.33K | 229.74K |
| Shares outstanding | 13.92M | 47.11M |
| Employees | 214 | 74 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Champions Oncology
CSBR stock →Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 214 employees
About MindWalk
HYFT stock →MindWalk Holdings Corp. operates as a bio-native AI company.
Health Care · Biotechnology: Pharmaceutical Preparations · 74 employees
CSBR vs HYFT FAQ
Which is bigger, Champions Oncology or MindWalk?
MindWalk (HYFT) is larger, with a market capitalization of $70.67M compared with $69.31M for Champions Oncology (CSBR).
Which stock has performed better over the past year, CSBR or HYFT?
CSBR returned -23.03% over the past 12 months, compared with -23.53% for HYFT (price return, excluding dividends). Past performance does not predict future results.
Are Champions Oncology and MindWalk in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Champions Oncology and Biotechnology: Pharmaceutical Preparations for MindWalk.